List Title | APhA DrugInfoLine

Focus on Lipids Care

SORT BY: Most Recent Most Viewed

May 4, 2015

Genetic testing helps predict cardiac risk, statin benefits

READ

PREVIEW
Use of a genetic risk score based on 27 genetic single nucleotide polymorphisms (SNPs) in more than 48,000 primary and secondary prevention patients helped determine who was at increased risk...
April 28, 2015

Coenzyme Q10 for statin-induced myopathy

READ

PREVIEW
In a meta-analysis of statin-related myopathy trials, supplementation with coenzyme Q10 did not decrease muscle pain or significantly change plasma creatinine kinase (CK) activity, compared with...
April 28, 2015

Most coronary risk calculators overestimate risk

READ

PREVIEW
Four out of five cardiovascular (CV) risk calculators, including the most recent one released by the American Heart Association/American College of Cardiology (AHA–ACC) in 2013, considerably...
April 7, 2015

Statins and clarithromycin: Role of non-CYP3A4 interactions

READ

PREVIEW
Results of a large population-based cohort study suggest that there may be a drug–drug interaction between clarithromycin, a potent cytochrome P450 3A4 (CYP3A4) inhibitor, and statins not...
March 24, 2015

Genetic variants may explain increased diabetes risk with statins

READ

PREVIEW
Genetic variants near the gene that encodes the HMG-coenzyme A (HMG-CoA) reductase protein may explain the association between statin use and an increased risk of type 2 diabetes, according to a...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.